• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备磷脂酰胆碱/胆盐双分子层囊泡提高依巴斯汀的溶解度和溶出度。

Improvement of solubility and dissolution of ebastine by fabricating phosphatidylcholine/ bile salt bilosomes.

机构信息

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, GC University Faisalabad, Pakistan.

Department of Chemistry, GC University, Faisalabad, Pakistan.

出版信息

Pak J Pharm Sci. 2020 Sep;33(5(Supplementary)):2301-2306.

PMID:33832904
Abstract

Although ebastine (EBT) can impede histamine-induced skin allergic reaction and persuade long acting selective H1 receptor antagonistic effects but its poor water solubility circumscribed its clinical application. The main objective of this research work was to improve the aqueous solubility and oral bioavailability of EBT by preparing EBT-loaded bilosomes (EBT-PC-SDC-BS). A thin film hydration method was used to prepare ebastine loaded bilosomes. The prepared-formulations were optimized considering size, morphology and entrapment efficiency. The SEM images revealed regular and spherical shape of bilosomes. Average size of the prepared EBT-PC-SDC-BS was 665.8 nm and zeta potential was around-32.9 mV with 89.05 % average entrapment efficiency (EE).Importantly, the solubility of EBT in water was amplified up to 17.9 μg/ml compared to pure drug (2 μg/mL) reflecting a highest solubility increase of 751 %. In vitro drug release results of prepared EBT-PC-SDC-BS exhibited improved release behavior. Finally, it is established from the results that the EBT-PC-SDC-BS could function as a favorable nano-carrier system to improve the solubility as well as dissolution of EBT.

摘要

尽管依巴斯汀(EBT)可以抑制组胺引起的皮肤过敏反应,并具有长效选择性 H1 受体拮抗作用,但由于其较差的水溶性限制了其临床应用。本研究工作的主要目的是通过制备载依巴斯汀双层囊泡(EBT-PC-SDC-BS)来提高 EBT 的水溶解度和口服生物利用度。采用薄膜水化法制备载依巴斯汀双层囊泡。考虑到粒径、形态和包封效率对制剂进行了优化。SEM 图像显示双层囊泡呈规则的球形。所制备的 EBT-PC-SDC-BS 的平均粒径为 665.8nm,zeta 电位约为-32.9mV,平均包封效率(EE)为 89.05%。重要的是,与纯药物(2μg/mL)相比,EBT 在水中的溶解度提高到 17.9μg/ml,溶解度提高了 751%。所制备的 EBT-PC-SDC-BS 的体外药物释放结果显示出改善的释放行为。最后,结果表明 EBT-PC-SDC-BS 可以作为一种有利的纳米载体系统,提高 EBT 的溶解度和溶解性能。

相似文献

1
Improvement of solubility and dissolution of ebastine by fabricating phosphatidylcholine/ bile salt bilosomes.制备磷脂酰胆碱/胆盐双分子层囊泡提高依巴斯汀的溶解度和溶出度。
Pak J Pharm Sci. 2020 Sep;33(5(Supplementary)):2301-2306.
2
Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.统计学优化胆盐组装纳米囊泡作为胡椒碱口服递送的潜在平台:在 MERS-CoV 感染的小鼠中增强抗病毒和抗炎活性。
Drug Deliv. 2021 Dec;28(1):1150-1165. doi: 10.1080/10717544.2021.1934190.
3
Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.甲磺酸依普罗沙坦载入双分子层囊泡作为潜在的纳米载体,用于治疗链脲佐菌素诱导的糖尿病大鼠的糖尿病肾病。
Eur J Pharm Sci. 2018 Jan 1;111:409-417. doi: 10.1016/j.ejps.2017.10.012. Epub 2017 Oct 10.
4
Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.评价双分子层囊泡作为盐酸替扎尼定经皮传递的纳米载体:体外和离体优化。
J Liposome Res. 2019 Jun;29(2):171-182. doi: 10.1080/08982104.2018.1524482. Epub 2018 Nov 13.
5
Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.组胺H1受体拮抗剂依巴斯汀在犬体内的药代动力学和药效学研究。
J Pharm Pharmacol. 1994 Jul;46(7):596-9. doi: 10.1111/j.2042-7158.1994.tb03864.x.
6
Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and skin deposition assay.将双分子层囊泡作为一种新型载体用于经皮递送达氟沙星治疗痤疮的研究:制备、表征和皮肤沉积研究。
J Liposome Res. 2020 Mar;30(1):1-11. doi: 10.1080/08982104.2019.1577256. Epub 2019 Jul 15.
7
Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility.载有水飞蓟宾-多烯磷脂酰胆碱复合物的混合胶束提高了药物溶解度。
Acta Pharmacol Sin. 2011 Jan;32(1):108-15. doi: 10.1038/aps.2010.192. Epub 2010 Dec 20.
8
Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.组胺H1受体拮抗剂依巴斯汀及其活性代谢物卡瑞斯汀在大鼠、豚鼠、犬和猴体内的比较药代动力学
Arzneimittelforschung. 1994 Jan;44(1):55-9.
9
Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.水飞蓟素通过包封于新型囊泡纳米系统双分子层脂质体中而增强的肝脏保护活性。
Drug Dev Ind Pharm. 2017 Dec;43(12):2043-2054. doi: 10.1080/03639045.2017.1361968. Epub 2017 Aug 13.
10
Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.依巴斯汀:其药理学特性及治疗过敏性疾病临床疗效的综述
Drugs. 1996 Feb;51(2):260-77. doi: 10.2165/00003495-199651020-00006.

引用本文的文献

1
Enhanced Oral Bioavailability of Progesterone in Bilosome Formulation: Fabrication, Statistical Optimization, and Pharmacokinetic Study.双体囊泡制剂中孕激素的口服生物利用度增强:制备、统计优化及药代动力学研究。
AAPS PharmSciTech. 2024 Feb 1;25(2):29. doi: 10.1208/s12249-024-02747-4.
2
Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study.用于亲脂性药物递送的双分子层脂质体和双分子层微粒:一项初步研究。
Antioxidants (Basel). 2023 Nov 21;12(12):2025. doi: 10.3390/antiox12122025.
3
Unlocking the Potential of Bilosomes and Modified Bilosomes: a Comprehensive Journey into Advanced Drug Delivery Trends.
解锁双层囊泡和改良双层囊泡的潜力:深入了解先进药物传递趋势的综合之旅。
AAPS PharmSciTech. 2023 Nov 21;24(8):238. doi: 10.1208/s12249-023-02696-4.
4
Improved Bioavailability of Ebastine through Development of Transfersomal Oral Films.通过开发传递体口腔膜提高依巴斯汀的生物利用度。
Pharmaceutics. 2021 Aug 23;13(8):1315. doi: 10.3390/pharmaceutics13081315.
5
Poloxamer-188 and d-α-Tocopheryl Polyethylene Glycol Succinate (TPGS-1000) Mixed Micelles Integrated Orodispersible Sublingual Films to Improve Oral Bioavailability of Ebastine; In Vitro and In Vivo Characterization.泊洛沙姆-188与聚乙二醇琥珀酸维生素E酯(TPGS-1000)混合胶束集成口腔崩解舌下片以提高依巴斯汀的口服生物利用度;体外和体内特性研究
Pharmaceutics. 2021 Jan 4;13(1):54. doi: 10.3390/pharmaceutics13010054.